Regeneron halts COVID-19 therapeutic trials on sick patients – One America News Network

(Photo by David Ramos/Getty Images)
OAN NewsroomUPDATED 3:50 PM PT Friday, October 30, 2020
‘Regeneron’ has paused its trials on the sickest patients following safety concerns.
According to reports on Friday, the pharmaceutical company decided to stop giving its antibody-drug to coronavirus patients on ventilators or those receiving high amounts of oxygen.
Announcing update on hospitalized #COVID19 patients in ongoing P2/3 study of Regenerons investigational antibody cocktail: https://t.co/6maNUOpruEpic.twitter.com/4xG0gg0qbT
…

Click here to view the original article.